Patent 7062314 was granted and assigned to Cardiac Pacemakers, Inc. on June, 2006 by the United States Patent and Trademark Office.
A device and method in which spectral analysis of heart rate variability is performed in order to assess autonomic balance. When a threshold level is reached, a diagnostic mode is triggered in which the device performs computationally intensive data analysis to assess the probability of a pathological event such as an arrhythmia occurring.